HIV Vaccine Development Faces Several Scientific Obstacles, Fauci Says In Opinion Piece
Main Category: HIV / AIDSAlso Included In: Immune System / Vaccines
Article Date: 02 Apr 2009 - 9:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
| Article Opinions: | 1 posts |
Although it is a "very reasonable query" to wonder why the scientific community has not developed an HIV/AIDS vaccine, research on developing such a vaccine has faced many scientific obstacles, Anthony Fauci, director of NIH's National Institute for Allergy and Infectious Diseases, writes in an MSNBC.com opinion piece. According to Fauci, scientists successfully have been able to develop vaccines for other diseases using a "proof of concept," which provides a "reasonably reliable" measure of the body's capacity to mount an effective immune response to an illness. Although the first attempts to develop an HIV vaccine followed this approach, these vaccines were ineffective because HIV "has never provided scientists with a proof of concept of predictable protection," Fauci writes. He continues, "Not a single individual is known to have spontaneously eradicated the virus," adding that for most people not taking antiretroviral drugs, HIV progression is "relentless, despite measurable, but apparently not completely adequate, HIV-specific immune responses."
According to Fauci, several factors account for the "inadequacy" of immune responses to HIV, including the virus' ability to establish latency and "hide" in host cells; its capacity to adapt and mutate; its ability to avoid immune responses; and its capacity to destroy or disable critical immune system cells. Fauci writes that considering these obstacles, HIV researchers "must learn how to prompt the human body to produce a protective immune response that is superior to that elicited by natural infection." In addition, HIV's ability to disseminate rapidly in the body following transmission requires vaccine researchers to "devise a vaccine that elicits an immune response that acts quickly to destroy the virus or learn how to extend the 'grace period'" between transmission and infection, Fauci writes.
According to Fauci, individuals in very rare circumstances have developed antibodies that neutralize HIV in the body, so it is "at least theoretically possible" to induce a similar immune response using a vaccine. In addition, "manipulating the innate immune system might alter the course of infection, perhaps widening the window of opportunity for viral eradication before HIV establishes an intractable reservoir of virus," Fauci writes. He continues that improved knowledge of the earliest stages of HIV could "lead to other strategies that extend the 'grace period' and allow the immune system time to more effectively respond." Finally, research on "elite controllers" -- HIV-positive people who do not progress to AIDS for several years or decades -- may provide a "different sort of 'proof of concept,'" Fauci writes. He continues that although "developing a vaccine capable of preventing infection is the ultimate goal, development of a vaccine that enables the recipient to control infection for years to decades would delay the need to initiate antiretroviral therapy and potentially even reduce secondary transmission to others."
Fauci writes that HIV vaccine development might never follow the path of earlier vaccines, and therefore "our efforts in HIV vaccinology must be part of a broader approach toward HIV prevention that includes the delivery of proven methods," including HIV testing, counseling, education, behavior change programs, condom distribution, drug and alcohol abuse prevention, needle-exchange programs, prevention of mother-to-child HIV transmission and male circumcision. Furthermore, new interventions such as topical microbicide gels and pre-exposure prophylaxis are undergoing "advanced testing," Fauci writes. However, he continues that "the development of an HIV vaccine must remain at the top of the global health research agenda." He concludes, "The obstacles to success are scientific obstacles, and I am cautiously optimistic that we will overcome these obstacles with scientific solutions, so there is no longer a need to ask the question: 'Why do we not yet have an AIDS vaccine?'" (Fauci, MSNBC.com, 3/31).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/144750.php>
APA
http://www.medicalnewstoday.com/releases/144750.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Other Possible Factors For HIV Vaccine Obstables
posted by Kok-Wah LEE @ Xpree Li on 9 Apr 2009 at 12:29 amDear All,
Anthony Fauci, who is a director of NIH's National Institute for Allergy and Infectious Diseases, expressed his view on the topic of "Scientific Obstacles of HIV Vaccine Development".
One can refer to online article [P1] for further exploration.
[P1] HIV Vaccine Development Faces Several Scientific Obstacles, Fauci Says In Opinion Piece
Main Category: HIV / AIDS
Also Included In: Immune System / Vaccines
Article Date: 02 Apr 2009 - 9:00 PDT
http://www.medicalnewstoday.com/articles/144750.php
The summarized HIV vaccine obstacles as pointed out by Anthony Fauci are as below:
[1] Virus' ability to establish latency and "hide" in host cells;
[2] Its capacity to adapt and mutate;
[3] Its ability to avoid immune responses; and
[4] Its capacity to destroy or disable critical immune system cells.
Other than that, as from the history on virus, its vaccine, genetics, and mutation, there may be other factors.
An organism can alive normally because of the normal functioning of all the systems. And yet, an organism, if it depends on another gender to produce the next generation, will need at least another mating partner. Hence, to kill an organism and yet smaller microorganism, it is either to stop the mating process to produce the next generation or to attack at least a system of the organism.
As we know, HIV virus has 9 genes. Each gene may be responsible for at least one system to keep the HIV virus alive. Due to the small HIV virus genome, then any attack to any one of HIV virus gene may be hard to recognize the exact gene, or may cause side effects to a the host organism containing the similar DNA base pair sequence for that particular gene. In other words, the smaller the genome of an organism, then it is harder to produce a virus vaccine without causing significant side effects to the host organism.
Moreover, due to the high mutation rate of HIV virus, then any possible HIV virus vaccine will have to consider a wide range of HIV gene mutation possibility. The higher the mutation rate of HIV virus for any of its gene among the 9 genes, then any possible HIV vaccine targeted to attack the function of that gene to kill the HIV virus shall have larger scope of flexibility, in which it also means higher risks to cause side effects to the host organism containing the similar DNA base pair sequence for that particular gene.
And yet, if a virus vaccine is able to cover a high mutation possibility, it is a question if the normal positive natural gene mutation of an organism will also be affected to produce self-improvement and better offspring.
These are my two cents of opinions from the points of possibilities.
For pre-reading materials [M1, M2]:
[M1] HIV - Wikipedia, the free encyclopedia
{
HIV is different in structure from other retroviruses. It is roughly spherical with a diameter of about 120 nm, around 60 times smaller than a red blood cell, yet large for a virus. It is composed of two copies of positive single-stranded RNA that codes for the virus's nine genes enclosed by a conical capsid composed of 2,000 copies of the viral protein p24.
}
http://en.wikipedia.org/wiki/HIV
[M2] New Stanford List Of HIV Mutations Vital To Tracking AIDS Epidemic
http://www.medicalnewstoday.com/articles/141428.php
Thanks & Bye.
Regards
Kok-Wah LEE @ Xpree Li
Email: E96LKW@hotmail.com
http://www.xpreeli.com
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



